mild-cognitive-impairment

Documents about mild-cognitive-impairment

• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data✰✰✰#123242Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data#125809Europe PMC
• Effectiveness of Attention/executivefunctions Training on Prospective Memory Abilities of Parkinson's Disease Subjects with Mild Cognitive Impairment and Healthy Aged Individuals: a Placebo-controlled Study with a Combined Immersive Virtual Reality and Telemedicine Approach#886215ClinicalTrials.gov
• Global research trends, reporting and handling of missing data in observational studies of type 2 diabetes mellitus with mild cognitive impairment from 2020 to 2025: a systematic review.#227973NCBI PubMed Central
• White matter microstructural integrity as a key to effective propagation of gamma entrainment in humans#348037KOASAS: KAIST Open Access Self-Archiving System
• LpD3.5 Intervention Study in Older Adults- LISA-I Trial#812348ClinicalTrials.gov
• Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS)#835427ClinicalTrials.gov
• Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?#852722ClinicalTrials.gov
• Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)#857720ClinicalTrials.gov
• Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease#910382ClinicalTrials.gov
• Machine Learning-Based Multiclass Classification of Cognitive Stages Using Plasma Biomarkers, Clinical Assessments, and Genetic Features: A Repeated, Nested Cross-Validation Study in ADNI with External Evaluation in CNTN#314712Europe PMC
• Gerontology Research Programme: The Singapore Longitudinal Ageing Studies (SLAS I & II)#1007236ClinicalTrials.gov
• Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease using Blood-Based Biomarkers and Amyloid-Beta PET: A Survival Analysis Approach#235048Harvard DASH
• The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review#253598Europe PMC
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot#833792ClinicalTrials.gov
• Auto-calibrating System for Upper Limb Disability Assessment, Neurological and Occupational Rehabilitation#903804ClinicalTrials.gov
• Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level#848200ClinicalTrials.gov
• Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)#854616ClinicalTrials.gov
• N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease#860140ClinicalTrials.gov
• Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 1)#872875ClinicalTrials.gov
• Understanding Brain Mechanisms Involved in Autobiographical Memory#894609ClinicalTrials.gov
• Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research#993763ClinicalTrials.gov
• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans#982363ClinicalTrials.gov
• SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and Dementia#992052ClinicalTrials.gov
• pCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD#911939ClinicalTrials.gov
• Devinime ilişkin kortikal potansiyellerin hafif bilişsel bozukluk ve orta evre alzheimer hastalığını değerlendirmede nöropsikoljik testler ile korelasyonu#458514Necmettin Erbakan University Institutional Repository
• Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping#850012ClinicalTrials.gov
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions#861087ClinicalTrials.gov
• Prevalence of Alzheimer's Disease Pathology in the Community#898345ClinicalTrials.gov
• Noninvasive Brain Stimulation Techniques and Their Efficacy in Treating Cognition and Memory in Mild Cognitive Impairment and Alzheimer’s Disease—A Systematic Review#231264Europe PMC
• Early-Stage Partner in Care Living Alone Plus#891881ClinicalTrials.gov
• Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase#1009478ClinicalTrials.gov
• A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease#805144ClinicalTrials.gov
• NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK#881426ClinicalTrials.gov
• Predicting Pre-dementia#969088ClinicalTrials.gov
• ADAI - Home Care in Intelligent Environments Clinical Care Ecosystem for the Management of Home Digital Therapies Through the Use of Assistive Robots and Clinical Predictive Systems Based on Artificial Intelligence Systems#162355ClinicalTrials.gov
• Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech#805905ClinicalTrials.gov
• Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease#185646IRIS
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease#852857ClinicalTrials.gov
• Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension#913489ClinicalTrials.gov
• Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease#182053Europe PMC
• The Impact of 6-months of Resistance Training on Brain and Muscle Health in Older Adults With MCI#830891ClinicalTrials.gov
• Down syndrome: Distribution of brain amyloid in mild cognitive impairment#491982eScholarship
• Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease#675974eScholarship